Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcγ receptors

Journal of Autoimmunity

Volumn 19, Issue 3, 2002, Pages 147-154

  Mold, Carolyn ^b   Baca, Rebecca ^b   Du Clos, Terry W ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b Department of Internal Medicine ^*  (United States)

Author keywords

Acute phase reactants; Apoptosis; Autoimmunity; Fc receptors; Phagocytosis

Indexed keywords

AUTOANTIGEN; C REACTIVE PROTEIN; CELL NUCLEUS ANTIGEN; FC RECEPTOR; OPSONIN; PENTRAXIN; SERUM AMYLOID P;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; OPSONIZATION; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; ULTRAVIOLET IRRADIATION; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; APOPTOSIS; C-REACTIVE PROTEIN; HUMANS; JURKAT CELLS; MACROPHAGES; MICE; PHAGOCYTOSIS; RECEPTORS, IGG; SERUM AMYLOID P-COMPONENT;

EID: 0036850609     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2002.0615     Document Type: Article

References (44)

1. Franc N.C., White K., Ezekowitz R.A.B. 1999. Phagocytosis and development: Back to the future. Curr. Opin. Immunol. 11: 47-52
2. Du Clos T.W. 1997. The interaction of C-reactive protein and serum amyloid P component with nuclear antigens. Mol. Biol. Rep. 23: 253-260
3. Du Clos T.W. 2000. Function of C-reactive protein. Ann Med. 32: 274-278
4. Pepys M.B., Dash A.C., Markham R.E., Thomas H.C., Williams B.D., Petrie A. 1978. Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin. Exp. Immunol. 32: 119-124
5. Pepys M.B., Baltz M.L., Gomer K., Davis J.S., Doenhoff M. 1979. Serum amyloid P component is an acute phase reactant in mouse. Nature 278: 259-261
6. Kaplan M.H., Volanakis J.E. 1974. Interactions of C-reactive protein with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J. Immunol. 112: 2135-2147
7. Mortensen R.F., Osmand A.P., Lint T.F., Gewurz H. 1976. Interaction of C-reactive protein with lymphocytes and monocytes: Complement-dependent adherence and phagocytosis. J. Immunol. 117: 774-781
8. Mold C., Gresham H.D., Du Clos T.W. 2001. Serum amyloid P component (SAP) and C-reactive protein (CRP) mediate phagocytosis through murine Fcγ receptors. J. Immunol. 166: 1200-1205
9. Bharadwaj D., Mold C., Markham E., Du Clos T.W. 2001. Serum amyloid P component binds to Fcγ receptors and opsonizes particles for phagocytosis. J. Immunol. 166: 6735-6741
10. Bharadwaj D., Stein M.P., Volzer M., Mold C., Du Clos T.W. 1999. The major receptor for C-reactive protein on leukocytes is FCγRII. J. Exp. Med. 190: 585-590
11. Stein M.P., Mold C., Du Clos T.W. 2000. C-reactive protein binding to murine leukocytes requires Fcγ receptors. J. Immunol. 164: 1514-1520
12. Ravetch J.V., Bolland S. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19: 275-290
13. Hind C.R.K., Collins P.M., Renn D., Cook R.B., Caspi D., Baltz M.L., Pepys M.B. 1984. Binding specificity of serum amyloid P component for the pyruvate acetal of galactose. J. Exp. Med. 159: 1058-1069
14. Loveless R.W., Floyd-O'Sullivan G., Raynes J.G., Yuen C.-T., Feizi T. 1992. Human serum amyloid P component is a multispecific adhesive protein whose ligands include 6-phosphorylated mannose and the 3-sulphated saccharides galactose, N-acetylglucosamine and glucuronic acid. EMBO J. 11: 813-819
15. Pepys M.B., Butler P.J.G. 1987. Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem. Biophys. Res. Commun. 148: 308-313
16. Volanakis J.E., Kaplan M.H. 1971. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc. Soc. Exp. Biol. Med. 136: 612-614
17. Volanakis J.E., Wirtz K.W.A. 1979. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature 281: 155-157
18. Li Y.P., Mold C., Du Clos T.W. 1994. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes. J. Immunol. 152: 2995-3005
19. Du Clos T.W., Zlock L.T., Rubin R.L. 1988. Analysis of the binding of C-reactive protein to histones and chromatin. J. Immunol. 141: 4266-4270
20. Du Clos T.W., Zlock L., Marnell L.L. 1991. Definition of a C-reactive protein binding determinant on histones. J. Biol. Chem. 266: 2167-2171
21. Du Clos T.W. 1989. C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J. Immunol. 143: 2553-2559
22. Tan E.M. 1982. Autoantibodies to nuclear antigens (ANA): Their immunobiology and medicine. Adv. Immunol. 33: 167-240
23. 1 mice treated with C-reactive protein. Clin. Immunol. Immunopath. 70: 22-27
24. Bickerstaff M.C.M., Botto M., Hutchinson W.L., Herbert J., Tennent G.A., Bybee A., Mitchell D.A., Cook H.T., Butler P.J.G., Walport M.J., Pepys M.B. 1999. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nature Med. 5: 694-696
25. Soma M., Tamaoki T., Kawano H., Ito S., Sakamoto M., Okada Y., Ozaki Y., Kanba S., Hamada Y., Ishihara T., Maeda S. 2001. Mice lacking serum amyloid P component do not necessarily develop severe autoimmune disease. Biochem. Biophys. Res. Commun. 286: 200-205
26. Burlingame R.W., Volzer M.A., Harris J., Du Clos T.W. 1996. The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice. J. Immunol. 156: 4783-4788
27. Rovere P., Sabbadini M.G., Fazzini F., Bondanza A., Zimmermann V.S., Rugarli C., Manfredi A.A. 2000. Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity. Arthritis Rheum. 43: 1663-1672
28. Casciola-Rosen L.A., Anhalt G., Rosen A. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179: 1317-1330
29. Burlingame R.W., Boey M.L., Starkebaum G., Rubin R.L. 1994. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J. Clin. Invest. 94: 184-192
30. Familian A., Zwart B., Huisman H.G., Rensink I., Roem D., Hordijk P.L., Aarden L.A., Hack C.E. 2001. Chromatin-independent binding of serum amyloid P component to apoptotic cells. J. Immunol. 167: 647-654
31. Marsh C.B., Wewers M.D., Tan L.C., Rovin B.H. 1997. Fcγ receptor cross-linking induces peripheral blood mononuclear cell monocyte chemoattractant protein-1 expression. J. Immunol. 158: 1078-1084
32. Spanier T.B., Mehmet C.O., Minanov O.E, Simantov R., Kisiel W., Stern D.M., Rose E.A., Schmidt A.M. 1998. Heparinless cardiopulmonary bypass with active-site blocked factor IXA: A preliminary study on the dog. J. Thorac. Cardiovasc. Surg. 115: 1179-1188
33. Wright S.D. 1986. Methods for the study of receptor-mediated phagocytosis. Methods Enzymol. 132: 205-221
34. Takai T., Li M., Sylvestre D., Clynes R., Ravetch J.V. 1994. FcR gamma chain deletion results in pleiotropic effector cell defects. Cell 76: 519-529
35. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184: 39-51
36. Gershow D., Kim S., Brot N., Elkon K.B. 2000. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: Implications for systemic autoimmunity. J. Exp. Med. 192: 1353-1363
37. Savill J.S., Wyllie A.H., Henson J.E., Walport M.J., Henson P.M., Haslett C. 1989. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83: 865-875
38. Fadok V.A., Bratton D.L., Henson P.M. 2001. Phagocyte receptors for apoptotic cells: Recognition, uptake, and consequences. J. Clin. Invest. 108: 957-962
39. Pepys M.B., Booth S.E., Tennent G.A., Butler P.J.G., Williams D.G. 1994. Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli. Clin. Exp. Immunol. 97: 152-157
40. Ioan-Facsinay A, de Kimpe SJ, Hellwig SM, van Lent PL, Hofhuis FM, van Ojik HH, Sedlik C, da Silveira SA, Gerber J, de Jong YF, Roozendaal R, Aarden LA, van den Berg WB, Saito T, Mosser D, Amigorena S, Izui S, van Ommen GJ, van Vugt M, van de Winkel JG, Verbeek JS 2002. FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 16
41. Barnes N, Gavin AL, Tan PS, Mottram P, Koentgen F, Hogarth PM 2002. FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 16
42. Sutterwala F.S., Noel G.J., Salgame P., Mosser D.M. 1998. Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J. Exp. Med. 188: 217-222
43. Wernersson S., Karlsson M.C.I., Dahlström J., Mattsson R., Verbeek J.S., Heyman B. 1999. IgG-mediated enhancement of antibody responses is low in Fc Receptor γ chain-deficient mice and increased in FcγRII-deficient mice. J. Immunol. 163: 618-622
44. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGFβ, PGE2, and PAF. J. Clin. Invest. 101: 890-898